The global laser treatment devices for varicose veins market is gaining strong momentum as demand for minimally invasive medical solutions continues to rise. According to a new report, the market was valued at $135.0 million in 2023 and is projected to reach $246.6 million by 2033, growing at a CAGR of 6.2% from 2024 to 2033. The surge is fueled by the increasing prevalence of venous disorders, growing preference for outpatient procedures, and rapid technological advancements in laser therapy.
Rising Demand for Effective Varicose Vein Treatments
Varicose veins, enlarged and twisted veins commonly found in the legs, affect millions of people worldwide, particularly older adults, sedentary workers, and those with a family history of venous issues. Beyond cosmetic concerns, untreated varicose veins can lead to serious complications such as chronic venous insufficiency and deep vein thrombosis.
Laser treatment devices, especially endovenous laser therapy (EVLT) systems, have emerged as a preferred option due to their precision, safety, and shorter recovery times compared to traditional surgical approaches. By using focused laser energy to close off affected veins, these devices help patients experience reduced pain, minimal scarring, and improved mobility.
“Patients are increasingly seeking treatments that not only address medical conditions but also enhance quality of life through faster recovery and better aesthetic outcomes,” said a senior market analyst. “This shift in patient preference is directly contributing to the rise of laser-based therapies.”
Key Market Drivers
Growing Prevalence of Venous Disorders – With a rapidly aging population and increasingly sedentary lifestyles, the number of individuals affected by varicose veins continues to grow.
Shift Toward Minimally Invasive Procedures – Patients prefer outpatient laser treatments that offer quicker recovery, reduced hospital stays, and lower overall treatment costs.
Technological Advancements in Laser Devices – Innovations such as next-generation EVLT platforms have improved treatment precision and reduced complications, encouraging greater adoption.
Increasing Awareness of Untreated Risks – Rising public awareness about complications of untreated varicose veins is prompting more patients to seek early intervention through laser treatments.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A324460
Regional Market Highlights
North America dominated the global market in 2023, supported by advanced healthcare infrastructure, strong patient awareness, and favorable reimbursement policies. The U.S. remains a hub for adoption of cutting-edge EVLT devices.
Asia-Pacific is forecasted to witness the fastest growth during 2024–2033, led by countries such as India and China. Factors driving this growth include higher healthcare investments, expanding infrastructure, and growing patient awareness about varicose vein treatments.
Europe also represents a significant market, particularly due to rising demand for outpatient treatments in countries like Germany, France, and the U.K.
Competitive Landscape
The market is highly competitive with a mix of established medical device companies and emerging innovators. Key players include:
AngioDynamics
Alma Lasers
biolitec Holding GmbH & Co KG
Sciton
Cutera, Inc.
WON TECH Co., Ltd.
LSO Medical
Notably, in September 2021, LSO Medical received CE mark approval for its Lumeseal laser platform, the next-generation successor to the Endotherme 1470 system. This development underscores the trend toward more precise and user-friendly devices designed to optimize clinical outcomes.
Opportunities Ahead
While high treatment costs and limited insurance coverage remain barriers in some regions, the overall outlook is promising. Emerging opportunities include:
Expansion in Emerging Economies – Rapidly developing healthcare infrastructure in Asia-Pacific, Latin America, and the Middle East is opening new avenues for device manufacturers.
Growing Aesthetic Demand – Beyond medical treatment, patient demand for aesthetic improvements is expected to fuel device adoption.
Rise in Outpatient and Home-Based Care – The global shift toward outpatient procedures is expected to further accelerate adoption of portable, patient-friendly laser treatment solutions.
Parent Market Connection
The broader varicose vein treatment market is also on an upward trajectory. According to Allied Market Research, it was valued at $376.6 million in 2017 and is projected to reach $589.1 million by 2025. As this market grows, laser treatment devices are emerging as a key segment, offering precise and effective alternatives to conventional therapies.
Market Segmentation
The laser treatment devices market is segmented as follows:
By Output Power:
0.1–15W
15–30W
Above 30W
By End User:
Hospitals
Clinics
Others
By Region:
North America
Europe
Asia-Pacific
LAMEA
Looking Forward
With a steady CAGR of 6.2% expected over the next decade, the laser treatment devices for varicose veins market is poised for sustained expansion. The convergence of aging demographics, rising disease prevalence, and breakthrough technologies positions the market as a critical growth area within the broader medical devices industry.
“As healthcare systems worldwide prioritize minimally invasive solutions, laser treatment devices will continue to gain momentum as both a medical necessity and a lifestyle choice,” the report concluded.
